RT Journal Article
SR Electronic
T1 MicroRNA signature predicts post-operative atrial fibrillation after coronary artery bypass grafting
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.21.24309328
DO 10.1101/2024.06.21.24309328
A1 Yerukala Sathipati, Srinivasulu
A1 Carter, Tonia
A1 Soodi, Deepa
A1 Somto, Nwaedozie
A1 Shukla, Sanjay K
A1 Petronovich, John
A1 Ingrid, Glurich
A1 Braxton, John
A1 Sharma, Param
YR 2024
UL http://medrxiv.org/content/early/2024/06/22/2024.06.21.24309328.abstract
AB Background Early detection of atrial fibrillation (AFib) is crucial for altering its natural progression and complication profile. Traditional demographic and lifestyle factors often fail as predictors of AFib, particularly in studies with small samples. This study investigated pre-operative, circulating microRNAs (miRNAs) as potential biomarkers for post-operative AFib (POAF) in patients undergoing coronary artery bypass grafting (CABG).Methods We used an array polymerase chain reaction method to detect pre-operative, circulating miRNAs in seven patients who subsequently developed POAF after CABG (cases) and eight patients who did not develop POAF after CABG (controls). The top 10 miRNAs from 84 candidates were selected and assessed for their performance in predicting POAF using machine learning models, including Random Forest, K-Nearest Neighbors (KNN), XGBoost, and Support Vector Machine (SVM).Results The Random Forest and XGBoost models showed superior predictive performance, with test sensitivities of 0.76 and 0.83, respectively. Differential expression analysis revealed four upregulated miRNAs—hsa-miR-96-5p, hsa-miR-184, hsa-miR-17-3p, and hsa-miR-200-3p—that overlapped with the AFib-miRNA signature. The AFib-miRNA signature was significantly associated with various cardiovascular diseases, including acute myocardial infarction, hypertrophic cardiomyopathy, and heart failure. Biological pathway analysis indicated these miRNAs target key signaling pathways involved in cardiovascular pathology, such as the MAPK, PI3K-Akt, and TGF-beta signaling pathways.Conclusion The identified miRNAs demonstrate significant potential as predictive biomarkers for AFib post-CABG, implicating critical cardiovascular pathways and highlighting their role in AFib development and progression. These findings suggest that miRNA signatures could enhance predictive accuracy for AFib, offering a novel, noninvasive approach to early detection and personalized management of this condition.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Marshfield Clinic Research Institute, Marshfield, WI.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board (IRB) of Marshfield Clinic Health System provided approval for the research described in this study. The IRB reference number is IRB-18-384. The IRB ensures that all research involving human participants adheres to ethical standards and regulatory requirementsI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are provided in the manuscript and supplemental information.